{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:51:14Z","timestamp":1789764674406,"version":"4.0.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Candidemia is a common healthcare-associated infection associated with substantial morbidity and mortality. Candida parapsilosis is among the most common causative species; it has a notable ability to form biofilms and colonize skin, facilitating patient-to-patient spread, and it is increasingly associated with fluconazole resistance. We aimed to describe temporal trends, clinical characteristics, and antifungal resistance patterns among C. parapsilosis candidemia hospitalizations in the United States during 2016\u20132024. We used the Premier Healthcare Database (which represents\u00a0&amp;gt;500 hospitals contributing laboratory data) to identify hospitalizations with\u00a0\u22651 blood culture positive for C. parapsilosis. We calculated rates of C. parapsilosis candidemia hospitalizations and described characteristics overall and stratified by time period (2016\u20132019, 2020\u20132021, 2022\u20132024). We also compared characteristics of hospitalizations with vs. without fluconazole resistance. Among 1943 C. parapsilosis candidemia hospitalizations, prevalence peaked during the COVID-19 pandemic (10.4 per 100\u2009000 hospitalizations in 2020\u20132021) and was highest among adults aged 45\u201364 years, male patients, and non-Hispanic Black patients. Many hospitalizations involved intensive care unit admission (67%), central venous catheter use (51%), and mechanical ventilation (37%). Fluconazole resistance rates increased from 3.1% in 2016\u20132019 to 11.7% in 2022\u20132024. In-hospital death or discharge to hospice was more frequent among hospitalizations involving fluconazole-resistant isolates vs. those without fluconazole-resistant isolates (42% vs. 28%, P\u00a0=\u00a0.017). Increased fluconazole resistance in C. parapsilosis is a growing public health concern. Surveillance, infection prevention and control practices, and routine antifungal susceptibility testing are essential to inform clinical management and public health strategies.<\/jats:p>","DOI":"10.1093\/mmy\/myaf109","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:54:54Z","timestamp":1763470494000},"source":"Crossref","is-referenced-by-count":2,"title":["Hospitalizations involving\n                    <i>Candida parapsilosis<\/i>\n                    bloodstream infection, United States, 2016\u20132024"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0458-2493","authenticated-orcid":false,"given":"Kaitlin","family":"Benedict","sequence":"first","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Toda","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn R","family":"Lockhart","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7925-2232","authenticated-orcid":false,"given":"Meghan","family":"Lyman","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A W","family":"Gold","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"18","key":"2025120503022168200_bib1","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med."},{"issue":"4","key":"2025120503022168200_bib2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025120503022168200_bib3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.vhri.2019.07.002","article-title":"The economic burden of candidemia and invasive candidiasis: a systematic review","volume":"21","author":"Wan\u00a0Ismail","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"4","key":"2025120503022168200_bib4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7404a1","article-title":"Population-based active surveillance for culture-confirmed candidemia\u201410 sites, United States, 2017\u20132021","volume":"74","author":"Jenkins","year":"2025","journal-title":"MMWR Surveill Summ"},{"issue":"6","key":"2025120503022168200_bib5","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3201\/eid1006.030873","article-title":"Candida parapsilosis characterization in an outbreak setting","volume":"10","author":"Kuhn","year":"2004","journal-title":"Emerg Infect Dis."},{"key":"2025120503022168200_bib6","doi-asserted-by":"publisher","first-page":"1010782","DOI":"10.3389\/ffunb.2022.1010782","article-title":"Fluconazole-resistant Candida parapsilosis: a new emerging threat in the fungi arena","volume":"3","author":"Escribano","year":"2022","journal-title":"Front Fungal Biol"},{"issue":"Suppl 2","key":"2025120503022168200_bib7","doi-asserted-by":"publisher","first-page":"s29","DOI":"10.1017\/ash.2023.255","article-title":"Fluconazole resistance in non-albicans Candida species in the United States, 2012\u20132021","volume":"3","author":"Jenkins","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2025120503022168200_bib8","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/infdis\/jiaf249","article-title":"Increasing fluconazole resistance in Candida parapsilosis: a 10-year analysis of blood culture isolates at a US Reference Laboratory (2015\u20132024)","volume":"232","author":"McHugh","year":"2025","journal-title":"J Infect Dis"},{"issue":"6","key":"2025120503022168200_bib9","doi-asserted-by":"publisher","first-page":"ofae264","DOI":"10.1093\/ofid\/ofae264","article-title":"Molecular and epidemiological investigation of fluconazole-resistant Candida parapsilosis\u2014Georgia, United States, 2021","volume":"11","author":"Misas","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"2025120503022168200_bib10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/cid\/ciab562","article-title":"The landscape of candidemia during the coronavirus disease 2019 (COVID-19) pandemic","volume":"74","author":"Seagle","year":"2022","journal-title":"Clin Infect Dis."},{"issue":"6","key":"2025120503022168200_bib11","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/s2666-5247(23)00067-8","article-title":"Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap","volume":"4","author":"Daneshnia","year":"2023","journal-title":"Lancet Microbe"},{"key":"2025120503022168200_bib12","doi-asserted-by":"publisher","first-page":"676177","DOI":"10.3389\/fcimb.2021.676177","article-title":"Clonal candidemia outbreak by Candida parapsilosis carrying Y132F in Turkey: evolution of a persisting challenge","volume":"11","author":"Arastehfar","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"2025120503022168200_bib13","doi-asserted-by":"publisher","first-page":"e02036","DOI":"10.1128\/aac.02036-20","article-title":"Hospital outbreak of fluconazole-resistant Candida parapsilosis: arguments for clonal transmission and long-term persistence","volume":"65","author":"Fekkar","year":"2021","journal-title":"Antimicrob Agents Chemother."},{"issue":"4","key":"2025120503022168200_bib14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/jof7040259","article-title":"Environmental clonal spread of azole-resistant Candida parapsilosis with Erg11-Y132F mutation causing a large candidemia outbreak in a Brazilian Cancer Referral Center","volume":"7","author":"Thomaz","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"3","key":"2025120503022168200_bib15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/cid\/ciae603","article-title":"Impact of fluconazole resistance on the outcomes of patients with Candida parapsilosis bloodstream infections: a retrospective multicenter study","volume":"80","author":"Vena","year":"2025","journal-title":"Clin Infect Dis."}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myaf109\/65388887\/myaf109.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/12\/myaf109\/65388887\/myaf109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/12\/myaf109\/65388887\/myaf109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:02:26Z","timestamp":1764921746000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myaf109\/8327628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaf109","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,19]]},"article-number":"myaf109"}}